- Issue price
- ₹90per share
- Issue size
- ₹50.77 Cr56,41,600 shares
- Face value
- ₹10per equity share
- Lot size
- 1,600 sharesMin. ₹1.44 L at the upper price
- Anchor biddingTue, 2026
- OpensThu, 2026
- ClosesMon, 2026
- ListingThu, 2026
Dates marked in the offer document as tentative. Times in IST.
Information only, not investment advice. This page provides information compiled from official offer documents for information purposes only. It is not investment advice or a recommendation to apply for, buy or sell any security. We are not a SEBI-registered investment adviser or research analyst. Investments in IPOs are subject to market risks; read the offer document carefully before investing.
Issue details
- Issue type
- Book built, fresh issue and offer for sale
- Fresh issue
- 45,61,600 shares (₹41.05 Cr)
- Offer for sale
- 10,80,000 shares (₹9.72 Cr)
- Total issue
- 56,41,600 shares (₹50.77 Cr)
- Market maker portion
- 2,83,200 shares
- Face value
- ₹10
- Listing at
- BSE SME
Source: ProspectusUpdated
Reservation
Share of the total issue- Retail33.3%
- Anchor28.4%
- QIB ex-anchor19.0%
- NII14.3%
- Market maker5.0%
| Category | Shares | Of net offer | Stated in RHP |
|---|---|---|---|
| Retail individual investors | 18,78,400 | 35.06% | 35% |
| Non-institutional investors (NII) | 8,06,400 | 15.05% | 15% |
| Qualified institutional buyers (QIB) | 26,73,600 | 49.90% | 50% |
| QIB, excluding anchor | 10,70,400 | 19.98% | — |
| Anchor investors | 16,03,200 | 29.92% | — |
| Market maker | 2,83,200 | — | — |
Source: ProspectusUpdated
Lot size
Amounts at ₹90 per share| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail individual investors | 1 | 1,600 | ₹1.44 L |
Source: ProspectusUpdated
Subscription
Category-wise subscription is published by the exchanges while the issue is open. It appears here once the figures are added.
Valuation
FY 2025-26- EPS (basic)
- ₹8
- RoNW
- 32.62%
- NAV per share (March 31, 2026)
- ₹24.54
- P/E (FY 2025-26 at lower price band)
- 10.63×
- P/E (FY 2025-26 at upper price band)
- 11.25×
Source: ProspectusUpdated
Financials
Standalone, restated · ₹ crore| Period ended | 31 Mar 2026FY 2025-26 | 31 Mar 2025FY 2024-25 | 31 Mar 2024FY 2023-24 |
|---|---|---|---|
| Revenue from operations | 105.71 | 65.03 | 30.18 |
| EBITDA | 19.06 | 12.25 | 5.45 |
| Profit after tax | 13.51 | 8.56 | 2.83 |
| Net worth | 41.41 | 27.90 | 9.86 |
| Reserves and surplus | 24.53 | — | — |
| Total borrowing | 0.00 | — | — |
FY 2025-26 vs FY 2024-25: revenue +62.6%, profit after tax +57.8%.
Source: ProspectusUpdated
About the company
The company supplies forensic kits, consumables, handheld devices, mobile crime scene investigation vehicles, cyber and digital forensic tools and DNA forensic solutions, mainly to police and government clients. It also rents forensic equipment and provides related training and support. It originally started in software development and moved into forensics from around 2008 onwards.
- Incorporated
- 2005
- Industry
- Forensic Equipment
- CIN
- U72200TN2005PLC055566
- Website
- kwickforensic.com
Source: ProspectusUpdated
Promoters and shareholders
| Name | Before issue | After issue | Shares offered |
|---|---|---|---|
| Shammer Saralal Shah | 53.76% | — | 2,16,000 |
| Sejal Shammer Shah | 17.78% | — | 6,48,000 |
| Tulsidas Hinduja Ashok Kumar | 6.54% | — | 2,16,000 |
Source: ProspectusUpdated
Objects of the issue
₹ crore| Purpose | Amount |
|---|---|
| Funding working capital requirement | 31.42 |
| General corporate purposes | 4.65 |
Source: ProspectusUpdated
Strengths and risks
Our summary of what the offer document statesStrengths
- Revenue has grown steadily over the last three fiscal years.
- Operates across several forensic product lines and holds multiple ISO certifications.
- Has no outstanding debt as of March 31, 2026.
- Serves a broad base of government and law-enforcement clients across India.
Risks
- Revenue is concentrated in Bihar and Gujarat.
- Most customers have no long-term agreements, so orders can be cancelled or changed.
- Top customers account for a large share of revenue.
- Receivable days are high because government payments are slow.
- Pre-IPO investors hold shares at a much lower cost and may sell after lock-in.
Source: ProspectusUpdated
Documents
Contacts
Source: ProspectusUpdated
Allotment status
Check whether shares were allotted on the official pages below, using your PAN, application number or DP/client ID. Results appear once the basis of allotment is finalised.
- Listing
Source: ProspectusUpdated
After listing
Listing price, day-one high and low, and the change from the issue price (₹90) appear here after the shares list on BSE SME.
Work out the gain or loss on allotted shares after charges and tax →
Frequently asked questions
When does the Kwick Forensic Solutions IPO open and close?
According to the Prospectus, the issue opens on Thursday, 27 August 2026 and closes on Monday, 31 August 2026.
What is the Kwick Forensic Solutions IPO price band?
The final issue price is ₹90 per share.
What is the lot size of the Kwick Forensic Solutions IPO?
One lot is 1,600 shares, which is ₹1.44 L at ₹90 per share.
Where will Kwick Forensic Solutions shares list?
On BSE SME. The tentative listing date is Thursday, 3 September 2026.
Who is the registrar of the issue?
Bigshare Services Private Limited (SEBI registration INR000001385). Allotment status is checked on the registrar's website.
How do I check the Kwick Forensic Solutions IPO allotment status?
Search by PAN, application number or DP/client ID on the registrar's website (Bigshare Services Private Limited) or the BSE website. Shares that are allotted are credited to your demat account; for an application that is not allotted, the blocked amount is released.
How will the money raised be used?
₹31.42 Cr for funding working capital requirement, ₹4.65 Cr for general corporate purposes.
Related IPOs
Spotted something wrong?
Our data comes from official offer documents, but mistakes can slip through. Report an error and tell us which figure looks wrong and where you saw the correct one (the offer-document page number helps). For anything else, see Contact.